Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04105270 |
| Title | P2 of RMT in Combo w Durvalumab or Durva + Chemo in Untreated Adenocarcinoma NSCLC |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Masonic Cancer Center, University of Minnesota |
| Indications | |
| Therapies |
Carboplatin + Durvalumab + Pemetrexed Disodium |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST